The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
N-benzyl-4-((2-chlorophenyl)sulfamoyl)-N-methylbenzamide ID: ALA5189191
PubChem CID: 39230111
Max Phase: Preclinical
Molecular Formula: C21H19ClN2O3S
Molecular Weight: 414.91
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: CN(Cc1ccccc1)C(=O)c1ccc(S(=O)(=O)Nc2ccccc2Cl)cc1
Standard InChI: InChI=1S/C21H19ClN2O3S/c1-24(15-16-7-3-2-4-8-16)21(25)17-11-13-18(14-12-17)28(26,27)23-20-10-6-5-9-19(20)22/h2-14,23H,15H2,1H3
Standard InChI Key: ICPFGTHYOUKTHB-UHFFFAOYSA-N
Molfile:
RDKit 2D
28 30 0 0 0 0 0 0 0 0999 V2000
-1.0691 0.6194 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3546 1.0317 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3572 0.6198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.3572 -0.2053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.3528 -0.6171 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.0691 -0.2090 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.7838 -0.6216 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
-2.4985 -0.2090 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-3.2131 -0.6216 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.2133 -1.4469 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9262 -1.8576 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6410 -1.4448 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.6426 -0.6237 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9308 -0.2073 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.1971 -1.3376 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-1.3720 -1.3376 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.0719 1.0324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.0719 1.8576 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1.7865 0.6198 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
2.5011 1.0324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2158 0.6198 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9306 1.0322 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6426 0.6202 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.6426 -0.2052 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.9324 -0.6170 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.2158 -0.2089 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7865 -0.2053 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.9308 0.6179 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0
2 1 2 0
3 2 1 0
4 3 2 0
5 4 1 0
6 5 2 0
1 6 1 0
6 7 1 0
7 8 1 0
8 9 1 0
10 9 2 0
11 10 1 0
12 11 2 0
13 12 1 0
14 13 2 0
9 14 1 0
7 15 2 0
7 16 2 0
3 17 1 0
17 18 2 0
17 19 1 0
19 20 1 0
20 21 1 0
22 21 2 0
23 22 1 0
24 23 2 0
25 24 1 0
26 25 2 0
21 26 1 0
19 27 1 0
14 28 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 414.91Molecular Weight (Monoisotopic): 414.0805AlogP: 4.41#Rotatable Bonds: 6Polar Surface Area: 66.48Molecular Species: NEUTRALHBA: 3HBD: 1#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: 8.70CX Basic pKa: ┄CX LogP: 4.09CX LogD: 4.07Aromatic Rings: 3Heavy Atoms: 28QED Weighted: 0.65Np Likeness Score: -1.95
References 1. Hanke T, Mathea S, Woortman J, Salah E, Berger BT, Tumber A, Kashima R, Hata A, Kuster B, Müller S, Knapp S.. (2022) Development and Characterization of Type I, Type II, and Type III LIM-Kinase Chemical Probes., 65 (19.0): [PMID:36136092 ] [10.1021/acs.jmedchem.2c01106 ]